XML 18 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2023
Sep. 30, 2022
Current    
Cash and cash equivalents $ 151,024 $ 149,158
Incentive and tax receivables 2,709 3,193
Prepaid expenses and other current assets 653 354
Total Assets 154,386 152,705
Current Liabilities    
Accounts payable 4,322 3,825
Accrued liabilities - Note 3 7,295 5,945
Deferred grant income - Note 4 917 444
Total Liabilities 12,534 10,214
Commitments and Contingencies - Note 6
Capital stock Authorized:10,000,000 preferred stock, par value $0.001 per share
Capital stock Authorized: 200,000,000 common stock, par value $0.001 per Issued and outstanding: 82,066,511 common shares (2022 - 77,942,815) 82 78
Additional paid-in capital 434,839 387,977
Accumulated deficit (293,069) (245,564)
Total Stockholders' Equity 141,852 142,491
Total Liabilities and Stockholders' Equity $ 154,386 $ 152,705